Innovatus Life Sciences Offshore Fund I, LP — Form D
Innovatus Life Sciences Offshore Fund I, LP of GRAND CAYMAN, E9, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2017-03-17. Industry: Pooled Investment Fund.
Offering
- Filed: 2017-03-17
- Form: D
- Accession: 0000943663-17-000107
- Industry: Pooled Investment Fund
- Exemptions: 3C, 3C.7
- Minimum investment: $5.0M
- Security types: fund interests
- SEC file number: 021-282838
Issuer
- Name: Innovatus Life Sciences Offshore Fund I, LP
- CIK: 0001700517
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2016
- Address: C/O MT. OZANNES CORP SVCS (CAYMAN) LTD, GRAND CAYMAN, E9, KY1-1108
- Phone: 212-698-4595
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Andrew Dym | Executive Officer | New York, NY |
| David Schiff | Executive Officer | New York, NY |
| N/A Innovatus Capital Partners, LLC | Promoter | New York, NY |
| Andrew Hobson | Executive Officer | New York, NY |
| N/A Innovatus Flagship Offshore Parent GP, LLC | Executive Officer | Grand Cayman, E9 |
| N/A Innovatus Life Sciences Offshore GP, LP | Executive Officer | Grand Cayman, E9 |
| N/A Innovatus Flagship Parent GP, LLC | Executive Officer | New York, NY |
| Joseph Schottland | Executive Officer | New York, NY |
Other filings by this issuer (2)
More